KIR3DL1 and myelodysplastic syndrome: Surprisingly, an almost 2-fold reduction of the killer immunoglobulin-like receptors (KIR) expression was found in MDS patients’ NK cells compared to HD (31.2% and 54.8%, respectively, p < 0.01, Supplementary Table 1).